Skip to main content
SpringerLink
Log in

Adult Rheumatoid Arthritis

  • Living reference work entry
  • Latest version View entry history
  • First Online:
Albert and Jakobiec's Principles and Practice of Ophthalmology

  • 61 Accesses

Abstract

Rheumatoid arthritis (RA) is a common, chronic, often debilitating autoimmune inflammatory disease affecting multiple organs. It develops as a result of an interplay between genetic and environmental factors. Persistent synovial inflammation, the characteristic feature, causes cartilage and bone destruction, leading to joint deformities and functional limitations. Nearly half of these patients show extraarticular manifestations, including ocular involvement. Early detection in RA is key to avoid potential sight-threatening complications. The main focus of the therapeutic approach to RA includes an aggressive treat-to-target intervention strategy designed to allow for adequate control of inflammation early in the course of the disease to limit structural and functional damage.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Kaplan MJ. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol. 2006;18:289–97.

    Article  CAS  PubMed  Google Scholar 

  2. Machold KP, Nell V, Stamm T, et al. Early rheumatoid arthritis. Curr Opin Rheumatol. 2006;18:282–8.

    Article  CAS  PubMed  Google Scholar 

  3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.

    Article  CAS  PubMed  Google Scholar 

  4. Aletaha D, Breedveld FC, Smolen JS. The need for new classification criteria for rheumatoid arthritis. Arthritis Rheum. 2005;52:3333–6.

    Article  PubMed  Google Scholar 

  5. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.

    Article  PubMed  Google Scholar 

  6. Tobón GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun. 2010;35(1):10–4.

    Article  PubMed  Google Scholar 

  7. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1316–22.

    Article  PubMed  Google Scholar 

  8. Sofat N, Wait R, Robertson SD, et al. Interaction between extracellular matrix molecules and microbial pathogens: evidence for the missing link in autoimmunity with rheumatoid arthritis as a disease model. Front Microbiol. 2015;5:783.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ollier WE, MacGregor A. Genetic epidemiology of rheumatoid disease. Br Med Bull. 1995;51(2):267–85.

    Article  CAS  PubMed  Google Scholar 

  10. Fuggle NR, Smith TO, Kaul A, et al. Hand to mouth: a systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Front Immunol. 2016;7:80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. elife. 2013;2:e01202.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8(1):43.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905.

    Article  CAS  PubMed  Google Scholar 

  14. Bodkhe R, Balakrishnan B, Taneja V. The role of microbiome in rheumatoid arthritis treatment. Ther Adv Musculoskelet Dis. 2019;11:1759720X19844632.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Turesson C, Matteson EL. Genetics of rheumatoid arthritis. Mayo Clin Proc. 2006;81:94–101.

    Article  CAS  PubMed  Google Scholar 

  16. Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. van Drongelen V, Holoshitz J. Human leukocyte antigen-disease associations in rheumatoid arthritis. Rheum Dis Clin North Am. 2017;43(3):363–76.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis. 2009;68(5):736–43.

    Article  CAS  PubMed  Google Scholar 

  19. Panayi GS. Hormonal control of rheumatoid inflammation. Br Med Bull. 1995;51:462–71.

    Article  CAS  PubMed  Google Scholar 

  20. Zheng J, Ibrahim S, Petersen F, Yu X. Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue. Genes Immun. 2012;13(8):641–52.

    Article  PubMed  CAS  Google Scholar 

  21. Malmström V, Catrina AI, Klareskog L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 2017;17(1):60–75.

    Article  PubMed  CAS  Google Scholar 

  22. Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A. 2011;108(42):17372–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ronnelid J, Wick MC, Lampa J, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005;64:1744–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Greiner A, Plischke H, Kellner H, Gruber R. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad Sci. 2005;1050:295–303.

    Article  CAS  PubMed  Google Scholar 

  26. Anderson J, Caplan L, Yazdany J, Robbins ML, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res. 2012;64:640–7.

    Article  Google Scholar 

  27. Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360–72.

    Article  PubMed  Google Scholar 

  28. van der Woude D, Rantapää-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis. 2010;69(8):1554–61.

    Article  PubMed  CAS  Google Scholar 

  29. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19.

    Article  CAS  PubMed  Google Scholar 

  30. Burmester GR, Dimitriu-Bona A, Waters SJ, Winchester RJ. Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts. Scand J Immunol. 1983;17(1):69–82.

    Article  CAS  PubMed  Google Scholar 

  31. Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, et al. M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1/M2 monocytes to osteoclastogenesis. Front Immunol. 2017;8:1958.

    Article  PubMed  CAS  Google Scholar 

  32. van Tuyl LH, Lems WF, Boers M. Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review. BMC Musculoskelet Disord. 2014;15:28.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Erickson AR, Cannella AC, Mikuls TR. Chapter 70: Clinical features of rheumatoid arthritis. In: 10th, editor. Kelley & Firestein’s textbook of rheumatology. Philadelphia: Elsevier; 2017. p. 1167–86.

    Chapter  Google Scholar 

  34. Lora V, Cerroni L, Cota C. Skin manifestations of rheumatoid arthritis. G Ital Dermatol Venereol. 2018;153(2):243–55.

    PubMed  Google Scholar 

  35. Mielke H, Daniel W, Deicher H, et al. The importance of skin wall immune deposits in the course of systemic and articular features of rheumatoid arthritis. Scand J Rheumatol. 1987;16:319–29.

    Article  CAS  PubMed  Google Scholar 

  36. Harper SL, Foster CS. The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin. 1998;38:1–19. Review.

    Article  CAS  PubMed  Google Scholar 

  37. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. St. Clair EW. Sjögren’s syndrome, Chapter 73. In: Kelley & Firestein’s textbook of rheumatology. 10th ed. Philadelphia: Elsevier; 2017. p. 1221–3.

    Chapter  Google Scholar 

  39. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9–16.

    Article  PubMed  Google Scholar 

  40. Murray PI, Rauz S. The eye and inflammatory rheumatic diseases: the eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis. Best Pract Res Clin Rheumatol. 2016;30(5):802–25.

    Article  PubMed  Google Scholar 

  41. Artifoni M, Rothschild P-R, Brézin A, Guillevin L, Puéchal X. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(2):108.

    Article  PubMed  Google Scholar 

  42. Fujita M, Igarashi T, Kurai T, et al. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005;140:808–13.

    Article  PubMed  Google Scholar 

  43. Beckman KA, Luchs J, Milner MS. Making the diagnosis of Sjögren’s syndrome in patients with dry eye. Clin Ophthalmol. 2015;10:43–53.

    Google Scholar 

  44. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–83.

    Article  PubMed  Google Scholar 

  45. Sjögren H, Block KJ. Keratoconjunctivitis sicca and the Sjögren syndrome. Surv Ophthalmol. 1971;16:145.

    Google Scholar 

  46. Lollett IV, Galor A. Dry eye syndrome: developments and lifitegrast in perspective. Clin Ophthalmol. 2018;12:125–39.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628.

    Article  PubMed  Google Scholar 

  48. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol. 1999;83:390–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. McGavin DDM, Williamson J, Forrester JV, et al. Episcleritis and scleritis: a study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60:192–226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Lin A, Bouchard CS. Non infectious keratitis. In: Opththalmology. 4th ed: Elsevier; 2014. p. 242–51.

    Google Scholar 

  51. Brown SI, Grayson M. Marginal furrows: a characteristic corneal lesion of rheumatoid arthritis. Arch Ophthalmol. 1968;79:563–7.

    Article  CAS  PubMed  Google Scholar 

  52. Mohan M, Panda A, Pattnaik NK, et al. Corneomalacia perforans in a patient with rheumatoid arthritis. Can J Ophthalmol. 1984;19:237–9.

    CAS  PubMed  Google Scholar 

  53. Ormerod LD, Fong LP, Foster CS. Corneal infection in mucosal scarring disorders and Sjögren’s syndrome. Am J Ophthalmol. 1988;105:512–8.

    Article  CAS  PubMed  Google Scholar 

  54. Alió JL, Artola A, Belda JI, Perez-Santonja JJ, Muñoz G, Javaloy J, et al. LASIK in patients with rheumatic diseases: a pilot study. Ophthalmology. 2005;112(11):1948–54.

    Article  PubMed  Google Scholar 

  55. Simpson RG, Moshirfar M, Edmonds JN, Christiansen SM, Behunin N. Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature. Clin Ophthalmol. 2012;6:1827–37.

    PubMed  PubMed Central  Google Scholar 

  56. U.S. Food and Drug Administration. When is LASIK not for me? [Internet]. FDA; 2018. Available from: https://www.fda.gov/medical-devices/lasik/when-lasik-not-me

  57. Chuck RS, Jacobs DS, Lee JK, Afshari NA, Vitale S, Shen TT, et al. Refractive errors & refractive surgery preferred practice pattern®. Ophthalmology. 2018;125(1):P1–P104.

    Article  PubMed  Google Scholar 

  58. Watanabe R, Ishii T, Yoshida M, Takada N, Yokokura S, Shirota Y, et al. Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review. Int J Rheum Dis. 2017;20(2):225–30.

    Article  PubMed  Google Scholar 

  59. Bettero RG, Cebrian RF, Skare TL. Prevalence of ocular manifestation in 198 patients with rheumatoid arthritis: a retrospective study. Arq Bras Oftalmol. 2008;71(3):365–9.

    Article  PubMed  Google Scholar 

  60. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119(1):43–50.

    Article  PubMed  Google Scholar 

  61. Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol. 1999;43:379–96.

    Article  CAS  PubMed  Google Scholar 

  62. Saripalli L, Harrington TM, Notz RG, Torretti D. Corneal melt in rheumatic disorders: effect of disease-modifying antirheumatic drugs on morbidity. J Clin Rheumatol. 2005;11:134–9.

    Article  PubMed  Google Scholar 

  63. Smith VA, Hoh HB, Easty DL. Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol. 1999;83:1376–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Cao Y, Zhang W, Wu J, Zhang H, Zhou H. Peripheral ulcerative keratitis associated with autoimmune disease: pathogenesis and treatment. J Ophthalmol. 2017;2017:7298026.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. Michels ML, Cobo LM, Caldwell DS, et al. Rheumatoid arthritis and sterile corneal ulceration. Arthritis Rheum. 1984;27:606–14.

    Article  CAS  PubMed  Google Scholar 

  66. Dayer J-M, Russell RGG, Krane SM. Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science. 1977;195:181–3.

    Article  CAS  PubMed  Google Scholar 

  67. Riley GP, Harrall RL, Watson PG, et al. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye. 1995;9:703–18.

    Article  PubMed  Google Scholar 

  68. Feder RS, Krachmer JH. Conjunctival resection for the treatment of the rheumatoid corneal ulceration. Ophthalmology. 1984;91:111–5.

    Article  CAS  PubMed  Google Scholar 

  69. Yagci A. Update on peripheral ulcerative keratitis. Clin Ophthalmol. 2012;6:747–54.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Palay DA, Stulting RD, Waring GO III, et al. Penetrating keratoplasty in patients with rheumatoid arthritis. Ophthalmology. 1992;99:622–7.

    Article  CAS  PubMed  Google Scholar 

  71. McGavin DD, Williamson J, Forrester JV, Foulds WS, Buchanan WW, Dick WC, et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60(3):192–226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Liu CS, Ramirez-Florez S, Watson PG. A randomised double blind trial comparing the treatment of episcleritis with topical 2-(2-hydroxy-4-methylphenyl) aminothiazole hydrochloride 0.1% (CBS 113A) and placebo. Eye. 1991;5:678–85.

    Article  PubMed  Google Scholar 

  74. Verhoeff FH, King MJ. Scleromalacia perforans. Arch Ophthalmol. 1938;20:1015.

    Article  Google Scholar 

  75. Rao NA, Font RL. Pseudorheumatoid nodules of the ocular adnexa. Am J Ophthalmol. 1975;70:471–8.

    Article  Google Scholar 

  76. Chang HK, Cho EH. A case of nodular scleritis in association with Behcet’s disease. Korean J Intern Med. 2001;16(1):47–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. McCluskey PJ, Wakefield D. Scleritis and episcleritis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby-Year Book; 1996. p. 642–66.

    Google Scholar 

  78. Jayson MIV, Jones DE. Scleritis and rheumatoid arthritis. Ann Rheum Dis. 1971;30:343–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmology. 1984;91:1253–63.

    Article  CAS  PubMed  Google Scholar 

  80. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology. 1994;101:1281–6.

    Article  CAS  PubMed  Google Scholar 

  81. Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 1999;106:1328–33.

    Article  CAS  PubMed  Google Scholar 

  82. Young RD, Watson PG. Microscopical studies of necrotising scleritis. I. Cellular aspects. Br J Ophthalmol. 1984;68:770–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Young RD, Watson PG. Microscopical studies of necrotising scleritis. II. Collagen degradation in the scleral stroma. Br J Ophthalmol. 1984;68:781–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Barrett AJ, Saklatvala J. Proteinases in joint tissue. In: Kelly WN, Harris Jr ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. Philadelphia: W.B. Saunders; 1989. p. 182–96.

    Google Scholar 

  85. Rao NA, Marak GE, Hidayat AA. Necrotizing scleritis: a clinicopathological study of 41 cases. Ophthalmology. 1985;92:1542–9.

    Article  CAS  PubMed  Google Scholar 

  86. Dana R. Treatment of scleritis. In: Trobe J, Romain P, editors. UpToDate. Waltham: UpToDate. https://www.uptodate.com. Accessed Oct 2019.

  87. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis therapy. Ophthalmology. 2012;119(1):51–8.

    Article  PubMed  Google Scholar 

  88. Androudi S, Dastiridou A, Symeonidis C, Kump L, Praidou A, Brazitikos P, et al. Retinal vasculitis in rheumatic diseases: an unseen burden. Clin Rheumatol. 2013;32(1):7–13.

    Article  PubMed  Google Scholar 

  89. Sarnat RL, Jampol LM. Hyperviscosity retinopathy secondary to polyclonal gammopathy in a patient with rheumatoid arthritis. Ophthalmology. 1986;93:124.

    Article  CAS  PubMed  Google Scholar 

  90. Sigal LH. The neurologic presentation of vasculitic and rheumatologic syndromes. Medicine (Baltimore). 1987;66:157–80.

    Article  CAS  Google Scholar 

  91. Konishi T, Saida T, Nishitani H. Orbital apex syndrome caused by rheumatoid nodules. J Neurol Neurosurg Psychiatry. 1986;49:460–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. McCormick SA, DiBartolomeo AG, Raju VK, et al. Ocular chrysiasis. Ophthalmology. 1985;92:1432–5.

    Article  CAS  PubMed  Google Scholar 

  93. Roquer J, Herraiz J, Maymo J, et al. Miller-Fisher syndrome during treatment with salts in a patient with rheumatoid arthritis. Arthritis Rheum. 1985;28:838–9.

    Article  CAS  PubMed  Google Scholar 

  94. Klingele TG, Burde RM. Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis. J Clin Neuroophthalmol. 1984;4:75–8.

    CAS  PubMed  Google Scholar 

  95. Hickling P, Beck M. Brown’s syndrome: an unusual ocular complication of rheumatoid arthritis. Ann Rheum Dis. 1991;50(1):66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Peponis V, Kyttaris VC, Chalkiadakis SE, Bonovas S, Sitaras NM. Ocular side effects of anti-rheumatic medications: what a rheumatologist should know. Lupus. 2010;19(6):675–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Rigas B, Huang W, Honkanen R. NSAID-induced corneal melt: clinical importance, pathogenesis, and risk mitigation. Surv Ophthalmol. https://doi.org/10.1016/j.survophthal.2019.07.001.

  98. Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386–94.

    Article  PubMed  Google Scholar 

  99. Emery P. Treatment of rheumatoid arthritis. BMJ. 2006;332:152–5.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Smolen JS, van der Heijde D, Machold KP, Aletaha D, Landewé R. Proposal for a new nomenclature of disease-modifying antirheumatic drugs. Ann Rheum Dis. 2014;73(1):3–5.

    Article  CAS  PubMed  Google Scholar 

  101. Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68(1):1–25.

    Article  Google Scholar 

  102. Chen Y, Friedman M, Liu G, Deodhar A, Chu CQ. Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders. Cytokine. 2018;101:78–88.

    Article  CAS  PubMed  Google Scholar 

  103. Mercer LK, Galloway JB, Lunt M, Davies R, Low AL, Dixon WG, et al. Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis. 2017;76(3):497–503.

    Article  PubMed  Google Scholar 

  104. Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, et al. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019;234(7):10018–31.

    Article  CAS  PubMed  Google Scholar 

  105. Romain P, Ramirez Curtis M. What’s new in rheumatology. UpToDate. Waltham: UpToDate. https://www.uptodate.com. Accessed Nov 2019.

  106. Albrecht K, Zink A. Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies. Arthritis Res Ther. 2017;19(1):68.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Alemao E, Litman HJ, Connolly SE, Kelly S, Hua W, Rosenblatt L, et al. Do poor prognostic factors in rheumatoid arthritis affect treatment choices and outcomes? Analysis of a US Rheumatoid Arthritis Registry. J Rheumatol. 2018; 45(10): 1353–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA

    C. Stephen Foster & Silvana Belotto

Authors
  1. C. Stephen Foster
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvana Belotto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Stephen Foster .

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, Oregon Health & Science University Department of Ophthalmology, Portland, OR, USA

    Daniel Albert

  2. Massachusetts Eye and Ear, Boston, MA, USA

    Joan Miller

  3. Department of Ophthalmology, University of Illinois at Chicago Department of Ophthalmology, Chicago, IL, USA

    Dimitri Azar

  4. Department of Ophthalmology, Harvard Medical School, Boston, MA, USA

    Lucy H. Young

Section Editor information

  1. Penn State College of Medicine, Penn State Eye Center, Hershey, Pennsylvania, USA

    Jeffrey M. Sundstrom

  2. Department of Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, USA

    David A. Quillen

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Foster, C.S., Belotto, S. (2021). Adult Rheumatoid Arthritis. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_296-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90495-5_296-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90495-5

  • Online ISBN: 978-3-319-90495-5

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Adult Rheumatoid Arthritis
    Published:
    28 August 2021

    DOI: https://doi.org/10.1007/978-3-319-90495-5_296-2

  2. Original

    Adult Rheumatoid Arthritis
    Published:
    31 July 2021

    DOI: https://doi.org/10.1007/978-3-319-90495-5_296-1

Search

Navigation